Cite Filings / CRVS
Feed Companies Filings Check
Sign in

CIK 0001626971 · Non-accelerated filer<br>Smaller reporting company

Corvus Pharmaceuticals, Inc.

Sign in to watch
Ticker
CRVS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464670809
Phone
(650) 900-4520
Business address
901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
Filings Insiders Search text
All 585 Financials 171 Shareholder Meetings 11 Executive Compensation 148 Insider Trading 252 Beneficial Ownership Interest 85 Business Combinations 126 Public Offerings 37 Mutual Funds and ETFs 10 Others 39
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-04-24
  3. DEF 14A Proxy Proxy Statement 2025-04-25
  4. DEF 14A Proxy Proxy Statement 2024-04-26
  5. DEF 14A Proxy Proxy Statement 2023-04-28
  6. DEF 14A Proxy Proxy Statement 2022-04-28
  7. DEF 14A Proxy Proxy Statement 2021-04-20
  8. DEF 14A Proxy Proxy Statement 2020-04-15
  9. DEF 14A Proxy Proxy Statement 2019-04-24
  10. DEF 14A Proxy Proxy Statement 2018-04-27
  11. DEF 14A Proxy Proxy Statement 2017-04-24
  12. PRE 14A Proxy Proxy Statement (Preliminary) 2017-04-05

Page 1 of 1 · 11 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…